UBS AM’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $223K | Hold |
|
|||||
|
2018
Q2 | $247K | Hold |
|
|||||
|
2018
Q1 | $269K | Buy |
|
|||||
|
2017
Q4 | $208K | Buy |
|
|||||
|
2017
Q3 | $277K | Buy |
|
|||||
|
2017
Q2 | $277K | Buy |
|
|||||
|
2017
Q1 | $235K | Hold |
|
|||||
|
2016
Q4 | $224K | Sell |
|
|||||
|
2016
Q3 | $391K | Hold |
|
|||||
|
2016
Q2 | $488K | Sell |
|
|||||
|
2016
Q1 | $372K | Sell |
|
|||||
|
2015
Q4 | $435K | Sell |
|
|||||
|
2015
Q3 | $4.54M | Sell |
|
|||||
|
2015
Q2 | $19.3M | Buy |
|
|||||
|
2015
Q1 | $23.5M | Buy |
|
|||||
|
2014
Q4 | $14.9M | Buy |
|
|||||
|
2014
Q3 | $14M | Sell |
|
|||||
|
2014
Q2 | $19.6M | Buy |
|
|||||
|
2014
Q1 | $20.9M | Buy |
|
|||||
|
2013
Q4 | $7.22M | Buy |
|
|||||
|
2013
Q3 | $242K | Hold |
|
|||||
|
2013
Q2 | $179K | Buy |
|